Search results for "HPV"
Cost-effectiveness of HPV vaccination after age 26 low, varies by risk factors
A model found that human papillomavirus (HPV) vaccination of men and women ages 27 to 45 years cost $2,005,000 per quality-adjusted life-year gained. Vaccinating patients in this age range who had more partners or had recently left a relationship was more cost-effective.
https://immattersacp.org/weekly/archives/2024/12/03/1.htm
3 Dec 2024
Home-based HPV screening appears cost-effective, study finds
In an economic evaluation of 19,851 female participants from a randomized clinical trial, incremental cost-effectiveness ratios for increased uptake of human papillomavirus (HPV) screening ranged from $86 to $146 per additional screening completed.
https://immattersacp.org/weekly/archives/2023/03/28/4.htm
28 Mar 2023
Little health benefit, higher costs likely with extended age limit for HPV vaccination
A modeling study examined four scenarios for extended vaccination in women and men up to ages 26, 30, 40, and 45 years.
https://immattersacp.org/weekly/archives/2019/12/10/1.htm
10 Dec 2019
Decrease in certain HPV types among unvaccinated women suggests herd protection
Prevalence of the four types of human papillomavirus (HPV) included in the original vaccine decreased most among women who were fully vaccinated but also decreased significantly among women who were unvaccinated between 2006 and 2017.
https://immattersacp.org/weekly/archives/2019/01/29/4.htm
29 Jan 2019
HPV testing compared with cytology may result in less cervical intraepithelial neoplasia
Clinicians will have to choose between primary human papillomavirus testing and co-testing based on modeling and cost-effectiveness studies, an editorial noted.
https://immattersacp.org/weekly/archives/2018/07/10/2.htm
10 Jul 2018
CDC recommends change to HPV vaccination schedule
Three doses had previously been recommended, but studies have suggested that 2 doses are just as effective in children who begin vaccination before age 15, the CDC's Advisory Committee on Immunization Practices decided.
https://immattersacp.org/weekly/archives/2016/10/25/5.htm
25 Oct 2016
Cervical cancer screening may be able to occur later, less often in HPV-vaccinated women, study suggests
When compared with no intervention, vaccination alone with no screening produced a 64.6% mean reduction in lifetime cervical cancer risk, and screening strategies increased this risk reduction to a range of 88% to 98%. The lowest cost-effectiveness ratio was seen with cytology-only screening every 5 years starting at age 35, compared with vaccination alone.
https://immattersacp.org/weekly/archives/2016/10/25/4.htm
25 Oct 2016